Updated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Estimates Based on Blood Donations, July 2020-December 2021.

Jones, Jefferson M; Opsomer, Jean D; Stone, Mars; Benoit, Tina; Ferg, Robyn A; Stramer, Susan L; Busch, Michael P

Jones, Jefferson M; Opsomer, Jean D; Stone, Mars; Benoit, Tina; Ferg, Robyn A; Stramer, Susan L; Busch, Michael P.

Jones JM; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia.
Opsomer JD; Westat, Rockville, Maryland.
Stone M; Vitalant Research Institute, San Francisco, California.
Benoit T; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia.
Ferg RA; Westat, Rockville, Maryland.
Stramer SL; Scientific Affairs, American Red Cross, Gaithersburg, Maryland.
Busch MP; Vitalant Research Institute, San Francisco, California.

JAMA ; 328(3): 298-301, 2022 07 19.

Article in English | MEDLINE | ID: covidwho-1971149

Subject(s)

Antibodies, Viral; Blood Donors; COVID-19 Vaccines; COVID-19; Seroepidemiologic Studies; Blood Donors/statistics & numerical data; COVID-19/epidemiology; COVID-19/prevention & control; Humans; SARS-CoV-2; United States; Vaccines

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Blood Donors / Seroepidemiologic Studies / COVID-19 Vaccines / COVID-19 / Antibodies, Viral Type of study: Observational study Topics: Vaccines Limits: Humans Country/Region as subject: North America Language: English Journal: JAMA Year: 2022 Document Type: Article Affiliation country: Jama.2022.9745

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google